218 related articles for article (PubMed ID: 7607565)
1. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.
Raunio H; Husgafvel-Pursiainen K; Anttila S; Hietanen E; Hirvonen A; Pelkonen O
Gene; 1995 Jun; 159(1):113-21. PubMed ID: 7607565
[TBL] [Abstract][Full Text] [Related]
2. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
3. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
4. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.
Autrup H
Mutat Res; 2000 Jan; 464(1):65-76. PubMed ID: 10633178
[TBL] [Abstract][Full Text] [Related]
7. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
8. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
Ozawa S
Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
Wormhoudt LW; Commandeur JN; Vermeulen NP
Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
[TBL] [Abstract][Full Text] [Related]
10. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors in individual responses to environmental exposures.
Hirvonen A
J Occup Environ Med; 1995 Jan; 37(1):37-43. PubMed ID: 7620941
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.
Ladona MG; Izquierdo-Martinez M; Posada de la Paz MP; de la Torre R; Ampurdanés C; Segura J; Sanz EJ
Environ Health Perspect; 2001 Apr; 109(4):369-75. PubMed ID: 11335185
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
Brockmöller J; Kaiser R; Kerb R; Cascorbi I; Jaeger V; Roots I
Pharmacogenetics; 1996 Dec; 6(6):535-45. PubMed ID: 9014203
[TBL] [Abstract][Full Text] [Related]
15. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
16. Metabolic genetic polymorphisms and susceptibility to lung cancer.
Bouchardy C; Benhamou S; Jourenkova N; Dayer P; Hirvonen A
Lung Cancer; 2001 May; 32(2):109-12. PubMed ID: 11325480
[TBL] [Abstract][Full Text] [Related]
17. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
[TBL] [Abstract][Full Text] [Related]
18. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
Nakajima T; Aoyama T
Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
[TBL] [Abstract][Full Text] [Related]
20. The role of individual susceptibility in cancer burden related to environmental exposure.
Bartsch H; Hietanen E
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]